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Abstract
This study examines the information potential of comprehensive two-dimensional gas chromatography combined with time-of-
flight mass spectrometry (GC×GC-TOF MS) and variable ionization energy (i.e., Tandem Ionization™) to study changes in
saliva metabolic signatures from a small group of obese individuals. The study presents a proof of concept for an effective
exploitation of the complementary nature of tandem ionization data. Samples are taken from two sub-populations of severely
obese (BMI > 40 kg/m2) patients, named metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO).
Untargeted fingerprinting, based on pattern recognition by template matching, is applied on single data streams and on fused
data, obtained by combining raw signals from the two ionization energies (12 and 70 eV). Results indicate that at lower energy
(i.e., 12 eV), the total signal intensity is one order of magnitude lower compared to the reference signal at 70 eV, but the ranges of
variations for 2D peak responses is larger, extending the dynamic range. Fused data combine benefits from 70 eV and 12 eV
resulting in more comprehensive coverage by sample fingerprints. Multivariate statistics, principal component analysis (PCA),
and partial least squares discriminant analysis (PLS-DA) show quite good patient clustering, with total explained variance by the
first two principal components (PCs) that increases from 54% at 70 eV to 59% at 12 eV and up to 71% for fused data. With PLS-
DA, discriminant components are highlighted and putatively identified by comparing retention data and 70 eV spectral signa-
tures. Within the most informative analytes, lactose is present in higher relative amount in saliva fromMHO patients, whereas N-
acetyl-D-glucosamine, urea, glucuronic acid γ-lactone, 2-deoxyribose, N-acetylneuraminic acid methyl ester, and 5-
aminovaleric acid are more abundant in MUO patients. Visual feature fingerprinting is combined with pattern recognition
algorithms to highlight metabolite variations between composite per-class images obtained by combining raw data from indi-
viduals belonging to different classes, i.e., MUO vs. MHO.
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Introduction
Comprehensive two-dimensional gas chromatography com-
bined with time-of-flight mass spectrometric detection
(GC×GC-TOF MS) is a multidimensional analytical platform
with great potentials for profiling and fingerprinting of com-
plex samples such as those typically considered in metabolo-
mics studies (e.g., bio-fluids, tissue extracts, and exhaled vol-
atile organic compounds [VOCs]) [1–7]. By this technique,
known and unknown analytes (i.e., targeted and untargeted
compounds) can be profiled in detail (i.e., detailed profiling)
thanks to the great separation power and the high sensitivity
achieved by band focusing with thermal modulation [8–11].
Moreover, a new concept of informative fingerprinting can be
exploited through the investigation of 2D separation patterns
with dedicated algorithms [4, 12]. In this case, chromato-
graphic fingerprinting and pattern recognition provide effec-
tive cross-sample analysis and sample-class discrimination,
with the intrinsic potential of also using analyte metadata for
identification. By this technique, untargeted investigations can
be followed by post-targeting to achieve a higher level of
information, helping in the interpretation of complex biologi-
cal phenomena. Human obesity is a particularly suitable clin-
ical condition owing to its multifold association with adverse
cardiometabolic events [13].
Mass spectrometry (MS) is a fundamental dimension for
any GC×GC platform, especially for complex samples analy-
sis. MS adds another dimension to the system, providing or-
thogonal information that can be exploited to make finger-
printingmore specific, for example by template matchingwith
MS similarity constraints [14], and more accurate when quan-
titation is performed.
Variable electron ionization (EI) MS systems can in-
crease the dimensionality of the analytical system and
thus the specificity of the comparative exploration.
Lowering the ionization energy can be done by simply
setting the system to operate in such a condition [15] or
by patented technologies that enable acquisition by
time-switching between two ionization energies. The lat-
ter, termed Tandem Ionisation™ [Select-eV™ - US pat-
ent number 9,786,480], operates with variable-energy EI
across single analytical runs. This patented system
adopts, in the ion source, high potentials to accelerate
electrons while reducing their energy through the ion
chamber [16]. This results in more efficient ionization
and reduced loss of sensitivity at low-energy EI with
enhanced intensity for structure-diagnostic ions [17].
Recent applications of this technique in the field of motor
oils [18] and diesel [19], blood volatiles [20], and food [17,
21] demonstrated that the combination of low ionization en-
ergies (10–16 eV) with standard 70 eV provide successful
discrimination of samples, with open possibilities to adopt
dedicated tandem data processing procedures.
In this study, variable ionization energy TOFMS is explored,
for the first time, as an additional dimension of a GC×GC plat-
form in saliva metabolome profiling and fingerprinting. In par-
ticular, the differential performance of an untargeted fingerprint-
ing algorithm, based on template matching, is examined by pro-
cessing single (separate low and high ionization energy) data
streams and fused (sum of low and high ionization energy) data
streams. The information potential of the system is evaluated
through its sensitivity (absolute and relative), response dynamic
range, signal response correlation, and fingerprint feature cover-
age. The challenges provided by this specific application are
rooted in the complex metabolic derangement induced by obesi-
ty, further complicated by comorbidities occurring in a subset of
recruited individuals.
For noninvasive diagnosis and monitoring of local and gen-
eral diseases, saliva is very accessible and easy to collect. Unlike
blood collection, which is almost always uncomfortable and
painful for the patient, or feces or urine analysis, which makes
people feel embarrassed, saliva collection is highly accessible, by
a simple spit into sterile receptacles. Repeated samples can be
collected, and diagnosis and monitoring using this method is an
innovative and attractive approach [22].
Most notably, saliva metabolites have been noted to paral-
lel metabolic alterations that occur in blood and may thus
reflect many pathophysiological and nutritional changes, as
well as exposure to medication and environmental factors
[23]. Here, we propose to test saliva as a reliable bio-fluid to
reveal informative metabolite patterns to determine whether
there is a specific salivary signature of obesity per se. There is
a limited number of reports on saliva of obese people. Obesity
has been demonstrated to lead to a change in the salivary
concentration of free sialic acid, total protein, and phosphate
as well as activity of peroxidase, which contributes to the
formation of dental caries [24]. While previous investigations
revealed a reduced antioxidant status and increased proinflam-
matory cytokine expression in obese individuals, other sali-
vary mediators relevant to obesity could be of metabolic im-
portance for potential clinical and therapeutic implications
[25, 26]. However, the majority of obese patients suffer from
comorbidities that may modulate saliva secretion either direct-
ly or through a required treatment, thus making it difficult to
distinguish which changes in salivary parameters could be
attributed purely to an increase in body mass. For these rea-
sons, here we focused our analysis on two different popula-
tions of subjects with severe obesity (body mass index,
BMI ≥ 40 kg/m2), according to their metabolic status.
Specifically, the recruited subjects were defined as “metabol-
ically unhealthy” obese (MUO) or “metabolically healthy”
obese (MHO), depending on whether or not they followed
normal metabolic parameters. Generally speaking, a person
with MHO has a BMI high enough to be classified as obese
but is without the metabolic abnormalities that are usually
linked to obesity [27].
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Materials and methods
Reference compounds and solvents
Pure standards of n-alkanes (from n-C7 to n-C30) for linear
retention index (IT) determination and 1,4-dibromobenzene
and 4-fluorophenylalanine for system evaluation and internal
standardization were from Merck (Milan, Italy).
The n-alkanes mixture was prepared in cyclohexane at a
concentration of 100 mg L−1; the internal standard (IS) 1,4-
dibromobenzene solution was prepared in toluene at a concen-
tration of 10 g L−1 and spiked to ready-to-inject derivatized
saliva samples at 50 mg L−1. The process verification IS, 4-
fluorophenylalanine, was prepared in methanol at a concen-
tration of 10 g L−1 and spiked to saliva aliquots before the
derivatization process at a final concentration of 50 mg L−1.
Pure standards for identity confirmation of pyruvic acid,
lactic acid, malonic acid, acetoacetic acid, phosphoric acid,
succinic acid, glyceric acid, fumaric acid, malic acid, citric
acid, alanine (Ala), asparagine (Asn), aspartic acid (Asp), cys-
teine (Cys), glutamic acid (Glu), glycine (Gln), isoleucine
(Ile), leucine (Leu), lysine (Lys), methionine (Met), ornithine
(Orn), phenylalanine (Phe), proline (Pro), serine (Ser), threo-
nine (Thr), tryptophan (Trp), tyrosine (Tyr), valine (Val),
glycerol, xylitol, mannitol, myo-inositol, fructose, galactose,
glucose, saccharose, lactose, and 4-chlorophenylalanine (in-
ternal quality control [IQC] for derivatization) were from
Merck (Milan, Italy).
Derivatization reagents and HPLC-grade solvents O-
methylhydroxylamine hydro-chloride (MOX), N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA), methanol,
pyridine, n-hexane, dichloromethane, and toluene were from
Merck (Milan, Italy).
Saliva samples and quality controls
This study includes patients recruited at the Istituto
Auxologico Italiano, Verbania, Italy [28, 29]. The height,
weight, and waist circumference of participants were mea-
sured as a part of regular assessment. Other subjects with body
mass index (BMI) of 40 kg/m2 or greater were recruited for
the study. In total, 34 obese men (BMI ≥ 40 kg/m2) were then
defined as metabolically unhealthy (MUO, n = 24) or meta-
bolically healthy (MHO, n = 10), depending on whether their
metabolic parameters were within normal ranges, i.e. high
fasting triglycerides, 1.7 mmol/L or greater (≥150 mg/dL);
reduced HDL cholesterol level (<1.03 mmol/L [<40 mg/
dL]); and whether their blood pressure was elevated
(≥130 mmHg systolic blood pressure or ≥ 85 mmHg diastolic
blood pressure) or on antihypertensive drug treatment and
fasting glucose concentration ≥ 5.6 mmol/L (≥100 mg/dL).
These criteria were taken from the metabolic syndrome defi-
nition [30] and have been used in similar studies. The
experimental procedure was approved by the ad hoc Ethical
Research Committee of the Istituto Auxologico Italiano
(Verbania, Italy). Written informed consent was obtained
from the patients. The study protocol conformed to the guide-
lines of the European Convention on Human Rights and
Biomedicine concerning biomedical research.
Saliva from a subset of obese individuals (MHO n = 3 and
MUO n = 5) randomly selected over the available samples and
quality controls (QCs) obtained by healthy, normal-weight
males (n = 4) of the same age were subjected to a standard
derivatization protocol [31] adjusted to comply for method
sensitivity and metabolite coverage. Sample preparation
consisted of the following steps: 100 μL of saliva and a suit-
able volume of process IS (4-fluorophenylalanine) were care-
fully mixed (Fisherbrand Whirlimixer vortex; Fisher
Scientific, Loughborough, Leicestershire, UK). Then, the so-
lution was dried under a gentle stream of nitrogen before the
addition of 25 μL of MOX (20 mg/mL in pyridine) and left to
react for 2 h at 60 °C. Next, 75 μL of BSTFAwere added, and
the mixture was incubated at 60 °C for 1 h. The resulting
sample solution was spiked with 1,4-dibromobenzene to a
final concentration of 50 mg L−1 and diluted in toluene to a
final volume of 200 μL. Analyses were immediately run with
duplicate injections for each sample; samples were random-
ized within a 24 h time frame after derivatization.
GC×GC-TOF MS and Tandem Ionization™: Instrument
set-up and conditions
GC×GC analyses were performed on an Agilent 7890B GC unit
coupled with a Bench TOF-Select™ system (Markes
International, Llantrisant, UK) featuring tandem EI equipped
with a SepSolve (Llantrisant, UK) preparation robot with auto-
mated tool change model PAL3-RTC. Hard ionization at 70 eV
was set for identity confirmation, while 12 eV was applied to
explore spectral and response complementarity. The ion source
and transfer line were set at 290 °C. TheMS optimization option
was set to operate in Tandem Ionisation™ with a mass range
between 45 and 1000m/z; data acquisition frequency was 50 Hz
per channel; filament voltage was set at 1.60 V.
The system was equipped with a two-stage KT 2004 loop
thermal modulator (Zoex Corporation, Houston, TX, USA)
cooled with liquid nitrogen controlled by an Optimode™ V.2
controller (SRA Instruments, Cernusco sul Naviglio, Milan,
Italy). The hot-jet pulse time was set at 350 ms; modulation
period was 5 s; and cold-jet total flow was progressively reduced
with a linear function from 30% of the mass flow controller
(MFC) at initial conditions to 8% at the end of the run.
The column set was configured as follows:1D DB-5 col-
umn (95% polydimethylsiloxane, 5% phenyl; 30 m ×
0.25 mm dc, 0.25 μm df) coupled with a
2D OV1701 column
(86% polydimethylsiloxane, 7% phenyl, 7% cyanopropyl;
2 m × 0.1 mm dc, 0.10 μm df) from J&W (Agilent, Little
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Falls, DE, USA). The first 0.80 m of the 2D column, connect-
ed in series to the 1D column by a silTite μ-union (Trajan
Scientific and Medical, Ringwood, Victoria, Australia), were
wrapped in the modulator slit and used as a loop capillary for
cryogenic modulation. The carrier gas was helium at a con-
stant flow of 1.6 mL min−1. The oven temperature program
was from 70 °C (2 min) to 120 °C at 10 °C min−1, then to
320 °C (1 min) at 4 °C min−1.
For saliva samples, 2.0 μL of the derivatized solution
(“Saliva samples and quality controls” section) were analyzed
under the following conditions: split/splitless injector in split
mode, split ratio 1:20, and injector temperature 300 °C. The
n-alkane liquid sample solution for IT determination was ana-
lyzed under the following conditions: split/splitless injector in
split mode, split ratio 1:50, injector temperature 300 °C, and
injection volume 1 μL.
Raw data acquisition and GC×GC data processing
Data were acquired by TOF-DS software (Markes International,
Llantrisant, UK) and processed using GC Image GC×GC
Software 2.9 (GC Image, LLC, Lincoln, NE, USA). Statistical
analysis was performed by XLSTAT 2014 (Addinsoft, New
York,NY,USA) and heatmap visualization byGENE-E version
3.0.77 (Broad Institute, Inc. Cambridge, MA, USA).
Method performance parameters: retention times
and response repeatability
Method validation was run for 2 weeks in order to evaluate the
repeatability of retention times and untargeted and targeted
(UT) peak response precision [32]. Retention times in both
chromatographic dimensions (1tR and
2tR) were collected from
the UT peak regions at 70 eV of analyzed samples [(4 QCs + 8
patients) × 2 process replicates × 2 analytical replicates] for a
total of 48 analytical runs processed. Results are reported as %
relative standard deviation (% RSD) in Electronic
Supplementary Material (ESM) Table S1, with quite good
retention time stability, with an average RSD of 0.20% for
1tR and 1.90% for
2tR. Response repeatability was calculated
on 552 reliable peaks from fused data and was based on nor-
malized responses from QC samples (4 QCs × 2 process rep-
licates × 2 analytical replicates = 16 analytical runs) acquired
over 2 weeks. As reported in ESM Table S1, repeatability %
RSD averaged 12.13, with a minimal value of 3.28 for peak
feature #134 and a maximum of 49.99 for #31.
UT fingerprinting workflow
The 2D data elaboration workflow is illustrated in Fig. 1 and
detailed in the ESM Fig. S1. It is based on an approach devel-
oped to comprehensively map UT features (i.e., peaks and
peak regions) for the most inclusive fingerprinting [33, 34].
In this specific application, the pre-targeting of analytes was
skipped by performing fully automated untargeted fingerprint-
ing on parallel data streams generated by Tandem
Ionization™ (70 and 12 eV channels). In addition, composite
chromatograms [17, 19] were computed by summing the par-
allel 12 and 70 eV data streams for each single analytical run,
and submitted to the UT processing workflow.
The template-matching strategy [14] is at the basis of the
comprehensive realignment of untargeted features across all
chromatograms. The metadata corresponding to all detected 2D
peaks and peak regions (retention times, MS fragmentation pat-
terns, and detector responses) are actively used to establish reli-
able correspondences between chemical entities across multiple
chromatograms. The specificity of the approach relies on the
constraints applied to validate positive matches. Based on previ-
ous studies aimed at validating the robustness and the accuracy of
the process [17, 35], a spectral-similarity threshold of 750 was
imposed for both direct match factor (DMF) and reverse match
factor (RMF) between reference (template) and analyzed
(candidate) MS signatures using the NISTMS Search algorithm,
version 2.0 (National Institute of Standards and Technology,
Gaithersburg, MD, USA) [35]. Matching was between “peak
spectra,” i.e., the MS signature from the largest data point within
the peak, and a signal-to-noise (S/N) threshold of 100 was fixed
to discard 2D peaks with inconsistent MS information.
The output of the full untargeted fingerprinting is a data
matrix of aligned 2D peaks and peak regions together with
related metadata (1D and2D retention times, MS fragmenta-
tion pattern, base peak and molecular ion m/z, and total ion
current [TIC] response), which is available for further process-
ing [36–38]. Here, there are three independent data matrices,
for the 70 eV, 12 eV, and fused data streams.
The untargeted fingerprinting (Step 1 in Fig. 1) was
performed automatically by GC Image Investigator™
version 2.9 software (GC Image, LLC, Lincoln, NE,
USA) to generate peak and peak-region features [12,
39]. For this purpose, peak detection thresholds were
set according to absolute responses (TIC counts) corre-
sponding to S/N threshold of 100 (i.e., 500,000 counts/
70 eV; 5000 counts/12 eV; 100,000 counts/fused data).
Values were confirmed by visual supervision to yield
comparable 2D peak detection across channels. The pro-
cess [4, 12, 33, 38–40] aligned the 48 chromatograms
[(4 QCs + 8 patients) × 2 process replicates × 2 analyti-
cal replicates] for each data stream (12 and 70 eV) plus
the fused data (12 + 70 eV) using a set of registration
peaks, named reliable peaks, to produce a composite
chromatogram from which peak regions were extracted.
Reliable peaks are those 2D peaks that were positively
matched across more than half of the chromatograms
(i.e., 25 of the 48 sample chromatograms).
The resulting templates with untargeted (reliable) peaks
and peak regions extracted by the composite chromatograms
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(i.e., the feature templates) are shown in Fig. 2 where the
saliva metabolome signature of an unhealthy obese (MUO)
patient is shown as it results from the 70 eV ionization channel
(2a), 12 eV (2b), and after fusion of the tandem data streams
(2c). The visual complexity of the templates is indicative of
the richness of the untargeted fingerprint. Details on the results
of this processing are discussed in “Full untargeted finger-
printing on single and fused data streams” section.
Targeting of informative compounds and potential
markers (Step 4 in Fig. 1) was performed for those peak
regions that demonstrated higher information potential
by unsupervised and supervised chemometrics (Step 3
in Fig. 1) for discriminating healthy from unhealthy
obese saliva signatures. Identification of targeted
analytes was carried out by matching candidate EI-MS
fragmentation patterns at 70 eV (NIST MS Search algo-
rithm, version 2.0) with those collected in commercial
and in-house databases (subject to a DMF threshold of
900 and RMF threshold of 950). In addition, linear re-
tention indices (IT) were adopted as a further constraint;
experimental values were compared with NIST reference





Alignment of 2D 
chromatograms and  
generaon of a composite 
chromatogram  
Definion of paern of 
detected 2D peaks 
Building of feature
templates with reliable 





Alignment of 2D 
chromatograms and  
generaon of a composite 
chromatogram  
Definion of paern of 




Determinaon of reliable Determinaon of reliable Determinaon of reliable 
registraon peaks
Alignment of 2D 
chromatograms and  
generaon of a composite 
chromatogram  
Definion of paern of 
peak-regions for all peak-regions for all peak-regions for all 
detected 2D peaks 
Cross-sample analysis
Unsupervised and supervised chemometrics 
Paern recognion and variables selecon
Candidate peaks selecon for targeng 
Targeting of candidate markers and informative compounds
Linear Retenon Index (IT) calibraon
Compound idenficaon (NIST Algorithm)








































templates with reliable 
peaks and peak -regions
Building of feature
templates with reliable 
peaks and peak -regions
Comprehensive pair-wise Comprehensive pair-wise 
Fig. 1 2D data elaboration workflow based on untargeted fingerprinting on single (12 and 70 eV) and fused (12 + 70 eV) data streams




70 eV data stream
Feature template




552 reliable peaks - green circles 
249 reliable peaks - green circles 
1205 peak - regions - red graphics
521 peak-regions - red graphics
355 reliable peaks - green circles 
454 peak-regions - red graphics
408 Rosso M.C. et al.
Results and discussion
In this study, the complex saliva metabolome was explored,
for the first time, by combining the separation power of
GC×GC with the complementary information provided by
TOF MS with variable ionization energy. The fingerprinting
process, based on pattern recognition (i.e., UT fingerprinting),
was applied in its full flexibility to cross-align features (2D
peaks and peak regions) between tandem signals and with the
fused data, to validate the role of informative analytes and to
facilitate their identification using the 70 eV spectra.
The next sections discuss full untargeted fingerprinting re-
sults and performance obtained by independent processing of
single (70 and 12 eV) and fused (70 eV + 12 eV) data streams
as illustrated at Steps 1 and 2 in Fig. 1).
Full untargeted fingerprinting on single and fused
data streams
The sample set under consideration in this study exhibited
several analytical challenges related to both the inter-
individual variability of the saliva metabolome [41] and its
intrinsic complexity due to the concurrent presence of comor-
bidity and metabolic derangements in obese patients. In such a
context, the combination of two ionization energies was ben-
eficial due to their different and complementary dynamic
ranges of response [19–21, 42]. It was demonstrated by pre-
vious investigations that when operating at lower ionization
energies (e.g., 10–16 eV), the generalized reduction in analyte
absolute response was accompanied by higher relative sensi-
tivity, expressed as signal-to-noise ratio (S/N), for several
analytes [17, 21]. This higher relative sensitivity was much
more evident for those analytes that showed the most dissim-
ilar fragmentation patterns between tandem channels.
These benefits were exploited to delineate metabolite sig-
natures capable of discriminating healthy from unhealthy
obese patients. Of course, this preliminary study is just a proof
of concept useful for evaluating the potential and the syner-
gism of adding extra dimensions at the MS detection level in
challenging scenarios. The limited number of samples avail-
able does not allow definitive generalized conclusions regard-
ing metabolomics; however, the fine-tuning of 2D data pro-
cessing strategies and the critical evaluation of the actual per-
formance of different workflows will inform future investiga-
tions with larger sample sets.
The 2D data processing strategy was conducted in a full
untargeted fashion, at the first stage. For a better understand-
ing of the signal characteristics, here follows some details on:
(a) background signal intensity before and after noise subtrac-
tion [43]; (b) number of detected 2D peaks above a fixed
threshold; and (c) range of variation for S/N and 2D peak
absolute response. All these data are summarized in Table 1
and refer to average values computed from the MUO #20
patient saliva replicates (n = 4).
Results confirm that at lower ionization energies, the
total signal intensity is lower (1840 vs. 23,090 counts)
by one order of magnitude, while for the fused data
stream, the average background level is close to that
at 70 eV (26,140 vs. 23,090 counts). After noise sub-
traction, applied here according to the Sternberg algo-
rithm [44], the resulting baseline was much more effec-
tively reduced at 12 eV, where the reduction was of two
orders of magnitude. This operation did not affect spec-
tral quality, as demonstrated by the number of reliable
peaks detected (see below).
The number of detected 2D peaks above the fixed TIC
response thresholds (“UT fingerprinting workflow” section)
and S/N ≥ 100 was comparable between 70 eV and the fused
data streams, with the latter exceeding the reference channel
(i.e., 70 eV) by 6%. On the other hand, as expected, at lower
energies, 2D peaks were 36% lower than those at 70 eV.
Absolute response values, calculated on the TIC channel, span
three orders of magnitude following a log-normal distribution
(data not shown), but with a wider range of variation calculat-
ed for the 12 eV channel: % relative standard deviation (RSD)
of 319% vs. 174% at 70 eV. This signal characteristic is of
great interest because it enables exploration of complex frac-
tions with a wider dynamic range. Analyte response/
concentration variations can be more effectively captured, es-
pecially on the higher range, at higher intensity values, where
at 70 eV detector saturation may easily occur. It should be
stressed that with band compression in space of thermal mod-
ulation, the analyte concentration gradient entering the ion
source and then reaching the detector is higher than with con-
ventional 1D GC-MS. The fused data stream, combining 70
and 12 eV signal characteristics, span a wider range of re-
sponses compared to the 70 eV with larger RSD.
The impact of signal characteristics can be appreciated by
untargeted fingerprinting processing (“UT fingerprinting
workflow” section). The single and summed (i.e., fused) data
streams were independently processed by Image Investigator
software (GC Image, LLC), applying the most relaxed condi-
tions [39] for reliable peak selection. By this approach,
untargeted 2D peaks that are matched (subject to retention
time constraints and 750 MS similarity) across at least half
of the chromatograms of the set (>24 of the 48 individual
chromatograms) are recorded and adopted as alignment points
for the construction of a composite image (ESM Fig. S2) for
Fig. 2 Pseudo-color chromatographic images corresponding to an
unhealthy obese (MUO) patient, resulting from the 70 eV ionization
channel (a), 12 eV (b), and after fusion of the tandem data streams (c).
Green circles indicate reliable 2D peaks, and red graphics indicate
untargeted peak regions. Details on feature template objects are also
reported
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each channel set. Results are summarized in Table 1 and
discussed in the following text.
According to signal characteristics, the number of reliable
peaks at 70 eV was higher than at 12 eV (355 vs. 249); this
result is in line with absolute response data and relative sen-
sitivity (S/N range), confirming that at higher ionization ener-
gies, the number of 2D peaks with consistent spectral infor-
mation is larger. For the fused data stream, the number of
reliable peaks was 55% greater than for 70 eV, indicating
the benefits of adding low-ionization spectral information to
the processing. At lower energies, the fragmentation is limit-
ed, and fragments with larger m/z values prevail [17,
21], with benefits for spectral interpretation [45].
Spectral dissimilarity and fragmentation pattern charac-
teristics are discussed in more detail for analytes of
interest in this application in “Informative metabolites
and their response from tandem signals” section.
The benefits of data fusion also are reflected in the number
of untargeted peak regions delineated over the composite
chromatogram(s) obtained by realignment and summing of
single or fused data images for the 48 runs. Peak regions
correspond to all detected 2D peaks above the TIC response
fixed thresholds (i.e., 500,000, 70 eV; 5000, 12 eV; 100,000,
fused data). Single ionization channels had almost the same
coverage by mapping 454 and 521 untargeted peak regions at
70 and 12 eV, respectively, whereas the fused data doubled
the feature coverage, reaching 1205 peak regions. This result
emphasizes the advantages of processing hybrid data,
exploiting in full the potential benefits of the tandem channels.
Last but not least, the feature template created from fused
data has a greater compositional coverage. For the single ion-
ization channels, the reliable peaks, with 355 at 70 eV or
249 at 12 eV, achieved a 99% and 98% matching rate on the
corresponding composite chromatograms, but covered only
18% and 14% of the detected 2D peaks. For fused data, the
552 reliable peaks achieved a 95.3% matching rate and cov-
ered 24% of the detected peaks.
The next section discusses results for unsupervised and
supervised statistical analyses of the saliva patterns resulting
from untargeted fingerprinting for the different detection
channels. 2D peaks and peak regions with meaningful varia-
tions are then examined to determine a putative identity and
hypothesize an informational role.
Chromatographic feature selection and results cross-
validation
As a first unsupervised exploration, principal component anal-
ysis (PCA) was conducted for all analyzed samples (48 runs)
using % response (based on TIC 2D volumes) for realigned
2D peak regions from the feature template. At this stage, QC
samples were included to provide a first impression of the
Table 1 Data processing
parameters based on single (12




detailed throughout the text
Parameter Detection channel
70 eV 12 eV Fused data
Average background intensity (counts) (retention window1D 15.5–19.0 min /2D 4.5–5.0 s)
Before noise subtraction 23,090 1840 26,140
After noise subtraction 1150 10 1140
No. detected 2D peaks S/N ≥ 100 517 336 549
Absolute response TIC (peak volume)
Min 5.17E+05 2.63E+04 1.08E+05
Max 1.69E+08 4.59E+07 2.12E+08
RSD 174% 319% 198%
Signal-to-noise ratio (S/N) TIC
Min 100 100 100
Max 59,007 36,209 52,954
RSD 251% 206% 226%
Fingerprinting and statistics
Feature template
No. reliable peaks 355 249 552
No. peak regions 454 521 1205
% Matched peaks on cumulative chromatogram 99% 97.6% 95.3%
No. 2D peaks S/N ≥ 100 1954 1729 2267
Supervised statistics
Kruskal–Wallis—Dunn’s test and Bonferroni correction
Peak regions meaningful p (alpha 0.05) 100 110 135
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overall quality of the responses and the degree of overlap
between saliva metabolome of obese patients and that of
healthy individuals. Results are visualized in Fig. 3. For all
detection channels (Fig. 3a, c, e), QCs are separately clustered
with confidence ellipses (95% of confidence), indicating re-
sponse stability. At the same time, saliva from obese patients
shows a certain degree of overlapping, in line with the com-
mon metabolic traits expected for this group. However, the
saliva metabolic signature from unhealthy obese patients
(UHO, blue circles) appear to be affected by a greater variabil-
ity, probably due to the presence of comorbidities.
PCA score plots based on the % response data from single
(Fig. 3a and c) or fused data (Fig. 3e) are highly concordant,
althoughwith 70 eV response data the total explained variance
reached the highest value (i.e., F1 and F2, 56.3%). The com-
bination of results from three independent elaborations takes
advantage of the complementary nature of tandem signals that
enables effective cross-validation.
The next step included a feature selection by removing from
the computation 2D peak regions whose variation between
UHO and MHO groups was not meaningful in the description
of the phenomenon. Due to the feature response distributions,
which are not normal, a nonparametric test was applied, i.e.,
Kruskal–Wallis, with post hoc correction by Dunn’s test and
Bonferroni correction. Peak regions with meaningful p values
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Fig. 3 Principal component
analysis (PCA) including all ana-
lyzed samples (48 runs) and based
on % response (TIC 2D volumes)
of realigned 2D peak regions
from the feature template: a
70 eV, c 12 eV, e fused data
streams. QC samples are retained
to show response consistency and
to illustrate the statistical distance
between the saliva of healthy
subjects (QCs) and that of MUO/
MHO patients. Feature reduction
by the Kruskal–Wallis test with
post hoc correction byDunn’s test
and Bonferroni correction results
in PCA loading plots of b
(70 eV), d (12 eV), and f (fused
data streams)
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Results are visualized in Fig. 3b d, f for 70 eV, 12 eV, and
fused data, respectively. The selection of variables had almost
the same results in terms of retained variables (on average 100
peak regions, Table 1) but with different outcomes on the total
explained variance. Fused data achieved 71% of the total var-
iance explained by the first two components, with also an
almost independent clustering of the groups of patients.
For 12 eV, the UHO samples were more dispersed, suggest-
ing that at lower energies, the wider dynamic range of responses,
although beneficial for more accurate profiling of metabolite
response variations, confounds intra-class variability.
Results for fused data streams showed the highest ex-
plained variance by the first two PCs and were further ex-
plored by supervised statistics (i.e., partial least squares dis-
criminant analysis [PLS-DA] and variable importance in pro-
jection [VIP]) to rank and select untargeted peak region fea-
tures with a role in the discrimination between UHO and
MUO saliva signatures and to focus identification efforts on
those potential markers.
Informative metabolites and their response from
tandem signals
Supervised statistics by PLS-DA and VIPs highlight discrim-
inant peak regions within those preselected at the previous
step. Features with VIPs ≥1 are listed in Table 2 together with
retention times in the two chromatographic dimensions (1tR;
2tR), estimated linear retention index (I
T) and literature refer-
ence (NIST library [46]), putative identification (criteria in
“UT fingerprinting workflow” section), and % of absolute
response variation between samples groups (MUO vs. MHO).
Within targeted analytes, those with the larger variations
were D-(+)-glucuronic acid γ-lactone (i.e., glucuronolactone
+325.2%), N-acetyl-D-glucosamine (+128.8%), urea
(+98.0%), 2-deoxy-D-ribose (+87.8%), N-acetylneuraminic
acid methyl ester (+77.2%), 5-aminovaleric acid (+75.3%),
3-methyl-2-oxobutanoic acid (+52.7%), and sucrose
(+40.9%). All of them were upregulated in unhealthy obese
patients with meaningful variations as indicated by VIP
values (Table 2). On the other hand, the saliva metab-
olome of healthy obese individuals was connoted by a
higher relative abundance of D-lactose (+365.0%), ser-
ine (+59.4%), and pyroglutamic acid (i.e., indicating L-
proline and L-glutamine, +17.8%).
Discriminant peak-region TIC responses were examined to
evaluate the degree of correlation between tandem signals.
Figure 4 shows linear regression results for N-acetyl-D-glu-
cosamine, lactose, and urea on the basis of TIC response at
12 eV (left side) and from fused signals (12 + 70 eV − SUM −
right side) compared to 70 eV taken as reference (independent
variable − x). Results are satisfactory: all determination coef-
ficients (R2) are above 0.800, indicating that tandem signals
are highly consistent and that their combination, by fused data
streams or by independent processing, might be beneficial for
the dynamic range of the method.
The differential sensitivity between the two channels (70
and 12 eV) and the dissimilarity between fragmentation pat-
terns is illustrated in Fig. 5 for one of the derivatization iso-
mers of N-acetyl-D-glucosamine and in ESM Fig. S3 for a
selection of metabolites covering different chemical classes.
With image colorization, the 70 eV channel (Fig. 5a) shows
highest absolute response compared to 12 eV (Fig. 5b), while
spectra (Fig. 5c) mainly differ for the presence of lower frag-
ments at 70 eV (73, 129, 147 m/z) that are less represented at
lower energy, in favor of larger fragments with a higher in-
trinsic informative role (202, 319, 333 m/z).
The interindividual variations in the salivary metabolome,
due to several confounding variables that might have a more
decisive impact on the distribution of metabolites, can be min-
imized by applying data processing strategies that accumulate
aligned data point features (i.e., TOF MS detector events) to
generate composite class images [47] for pair-wise compari-
sons. Based on the fingerprinting workflow illustrated in Fig.
1, composite class images representing the salivary metabolite
signatures of healthy (MHO) and unhealthy (MUO) obese
patients were built from fused data images. In this way, com-
parative visualization [12] was adopted to highlight pattern
variations between groups. Figure 6a shows a colorized fuzzy
ratio rendering [40] that illustrates the differential response
betweenMUO (analyzed image) and MHO (reference image)
composites. Areas in the pattern colored in red correspond to
components whose relative TIC response (normalization is
done on the total image response [40]) was higher in the
reference class image (i.e., MHO), whereas areas in green
are components with higher responses in the analyzed class
image (i.e., MUO). Except for urea, eluting early in the chro-
matogram (peak region #351) and present in higher amounts
in unhealthy obese patients, there is a clear pattern of upregu-
lated di-saccharides at higher retention indexes (Fig. 6c) that
were putatively identified as lactose isomers. On the other
hand, among monosaccharides (Fig. 6b), the trends for fruc-
tose (#376) and glucose (#27) are in contrast—see green and
red colorization, respectively—while N-acetyl-D-
glucosamine isomers (#19 and #282) were clearly upregulated
in MUOs. Univariate statistics on analytes’ relative distribu-
tions in sample classes, by box-plot visualization, is provided
as ESM Fig. S4.
Insights on saliva metabolite differential signatures
With respect to biological interpretation of the analytical data,
although sampling was limited to a few subjects within all
recruited patients in the global study, it appears that saliva of
metabolically unhealthy obese patients had a higher relative
abundance of N-acetyl-D-glucosamine. This amide derivative
of glucose in mammals is generally bonded to serine or























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































413Exploring extra dimensions to capture saliva metabolite fingerprints from metabolically healthy and...
threonine residues of a protein, giving the O-GlcNAcylation.
O-GlcNAcylation appears to have a role in autophagy, insulin
signaling, and stress response [48], while large amounts of O-
GlcNAcylation resulted in insulin resistance in adipocytes
[49]. The MUO population, when profiled by multiplexed
lectin microarray for carbohydrates present on proteins, result-
ed in clear and distinctive patterns of GlcNAcylation [28].
Urea, another informative analyte from the fingerprinting
analysis, is the principal carrier of waste nitrogen derived from
the protein catabolism. High levels of salivary urea were
found to be abundant in chronic kidney disease patients
[50], while higher D-(+)-glucuronic acid γ-lactone amounts
were found in patients with hepatic steatosis [51]. On the other
hand, 5-aminovaleric acid (+75.3% in MUO), a lysine degra-
dation product, is a normal metabolite present in human sali-
va, with a tendency to elevated concentration in patients with
chronic periodontitis. Bacterial contamination and decompo-
sition of salivary proteins is primarily responsible for elevated
salivary levels of this metabolite [52].
Data on saliva level/concentration of lactose are lacking,
although evidence of urine excretion of this metabolite is cor-
related to milk consumption [53] and, in its turn, also related
to fermentation by gut microbiota that in obesity has a great















































































Urea SUM vs.70 eV (R²=0.8156) 
Fig. 4 Linear regression results for discriminant analytes (i.e., N-acetyl-D-glucosamine, lactose, and urea) on the basis of TIC response data at 12 eV (left
side) and from fused signals (12 + 70 eV − SUM − right side) compared to 70 eV taken as reference (independent variable − x)
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N-Acetyl-D-glucosamine, tetrakis(trimethylsilyl) ether, methyloxime(syn)
a-70 eV b-12 eV
c- 12 eV vs. 70 eV
Fig. 5 Enlarged areas of the
contour plots corresponding to the
elution region of a N-acetyl-D-
glucosamine isomer: a 70 eV
ionization; b 12 eV energy; c
head-to-tail comparison of the
resulting fragmentation pattern
between the two channels























Fig. 6 Colorized fuzzy ratio
rendering (a) of the differential
response between composite class
images from MUO (analyzed
image) and MHO (reference
image) samples. Areas in the
pattern colored in red correspond
to features whose relative TIC
response (normalization is done
on the total image response) is
higher in the reference class
image (i.e. MHO), while areas in
green represent features with
higher responses in the analyzed
class image (i.e., MUO).
Monosaccharide (b) and
disaccharide (c) regions are
detailed in enlarged areas
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When compared with QC patterns, obtained from
healthy male subjects, both MHO and MUO were char-
acterized by higher levels of butyric acid and myo-ino-
sitol, previously confirmed to be obesity markers found
in blood and urine [55, 56].
The role of dietary carbohydrates in the development and
maintenance of obesity is a topic that is receiving increasing
attention [57]. Glucose is catabolized via glycolysis to pyru-
vate, which under aerobic conditions, is converted into acetyl
coenzyme A, the entry point into the tricarboxylic acid (TCA)
cycle. Under anaerobic conditions, pyruvate is instead con-
verted into lactate by lactate dehydrogenase. In obesity,
the levels of glucose, lactic acid, fructose, glycerol,
mannose, sorbitol, xylose, gluconic acid, and glucuronic
acid are increased [58, 59].
Overall, preliminary results from saliva signatures from
obese patients indicate a hitherto unrecognized and fairly nov-
el role for carbohydrate and amino acid metabolism in obesity
while suggesting that altered metabolic fingerprints may con-
tribute to a better understanding of the pathogenesis of differ-
ent clinical contexts linked to obesity, specifically MHO vs.
MUO, but also to better elucidate the inflammatory milieu
detectable in the saliva of MUO, which could help to better
prevent many obesity-associated pathological conditions, in-
cluding cardiovascular and metabolic diseases [28].
Conclusions
Comprehensive two-dimensional gas chromatography, when
combined with Tandem Ionization™ TOFMS, improves confi-
dence in untargeted fingerprinting of complex samples.
Chromatographic fingerprints from saliva metabolites obtained
by summing raw MS data acquired at two ionization energies
(i.e., 12 and 70 eV) had a larger number of reliable features (i.e.,
2D peaks reliably matched across chromatograms), indicating a
higher spectral consistency and stability. Low-ionization energy
data showed a wider dynamic range of responses and good cor-
relation with 70 eV response. Moreover, lower ionization limited
fragmentation by producing MS spectral signatures dominated
by medium-to-high m/z fragments with an intrinsically higher
information role on analyte identity.
Although the very limited number of samples does not
allow conclusive results, analytes discriminating saliva signa-
tures of MUO vs. MHO were putatively identified. Their in-
formation role might be now be placed in the more general
context of metabolic derangement caused by obesity and con-
current alterations due to comorbidities. The study provides a
proof of concept on the advantages of adding extra dimen-
sions to the analytical system adopted for chromatographic
fingerprinting of biological fluids; it delineates an effective
workflow that can be adopted with a larger data set.
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